BeOne Medicines - Income from Continuous Operations 2014-2025 | ONC
BeOne Medicines - income from continuous operations for the twelve months ending March 31, 2025 was $-0.392B, a 49.98% decline year-over-year.
- BeOne Medicines - annual income from continuous operations for 2024 was $-0.645B, a 26.87% decline from 2023.
- BeOne Medicines - annual income from continuous operations for 2023 was $-0.882B, a 56% decline from 2022.
- BeOne Medicines - annual income from continuous operations for 2022 was $-2.004B, a 37.45% increase from 2021.